LongeVC is a Washington, D.C.-based venture capital firm investing in early-stage biotech and longevity companies in the United States. The firm focuses on therapeutics, diagnostics, prevention, personalized medicine, pre-clinical and clinical-stage drug development, medical devices, health testing, AI-enabled drug discovery and longevity infrastructure, making it relevant for founders building science-driven healthcare and life sciences companies.